Application for olanzapine is under FDA review.
1 report, 1 independent
Updated Jun 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Application for olanzapine is under FDA review.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
Related events
- The FDA is reviewing a drug approval application for a condition involving the company GAD.
- The FDA recommended advancement for a new drug application submitted by a company.
- Kowa's New Drug Application (NDA) for drug K-911 was accepted by the FDA for review.
- A Patient Assistance Program has been established to cover prescription medications that have received FDA approval.
- The FDA is currently reviewing new drug applications for market entry.